Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

Ítems similars

• Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).
  per: Tyndale, R F, et al.
  Publicat: (1991)
• Sparteine oxidation is practically abolished in quinidine-treated patients.
  per: Brinn, R, et al.
  Publicat: (1986)
• Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
  per: Eichelbaum, M, et al.
  Publicat: (1983)
• S-mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.
  per: Basci, N E, et al.
  Publicat: (1994)
• Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism.
  per: Brøsen, K, et al.
  Publicat: (1991)